COMUNICADO: C8 MediSensors consigue la aprobación de la Marca CE para el sistema de monitorización óptico de glucosa de C8 MediSenso

        
        1) The Diabetes Control and Complications Trial Research Group. The effect
          of intensive treatment of diabetes on the development and progression of long-term
          complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(14):977-86
        2) UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control
          with sulphonylureas or insulin compared with conventional treatment and risk of
          complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352(9131
          ):837-53
        3) Monnier L, Colette C, Boegner C, et al. Continuous glucose monitoring in
          patients with type 2 diabetes: Why? When? Whom? Diabetes Metab 2007;33(4):247-52
        4) Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute
          glucose fluctuations compared with sustained chronic hyperglycemia in patients with
          type 2 diabetes. JAMA 2006;295(14):1681-7
        5) Hirsch IB, Abelseth J, Bode BW, et al. Sensor-augmented insulin pump therapy:
          results of the first randomized treat-to-target study. Diabetes Technol Ther
          2008;10(5):377-83
        6) Ceriello A. The glucose triad and its role in comprehensive glycaemic
          control: current status, future management. Int J Clin Pract 2010;64(12):1705-11
        7) Beck RW, Buckingham B, Miller K, et al. Factors predictive of use and of
          benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care
          2009;32(11):1947-53
        8) Anderson J, Effect on glycemic control by short- and long-term use of
          continuous glucose monitoring in clinical practice. J Diabetes Sci Technol
          2011;5(6):1472-8
        9) Bailey TS, Zisser HC, Garg SK. Reduction in hemoglobin A1C with real-time
          continuous glucose monitoring: results from a 12-week observational study. Diabetes
          Technol Ther 2007;9(3):203-10
          10) Chico A, Vidal-Ríos P, Subirà M, Novials A. The continuous glucose
          monitoring system is useful for detecting unrecognized hypoglycemias in patients with
          type 1 and type 2 diabetes but is not better than frequent capillary glucose
          measurements for improving metabolic control. Diabetes Care 2003;26(4):1153-7
          11) Garg S, Jovanovic L. Relationship of fasting and hourly blood glucose levels
          to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using
          a 7-day continuous glucose sensor. Diabetes Care 2006;29(12):2644-9
          12) Garg S, Zisser H, Schwartz S, et al. Improvement in glycemic excursions with
          a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial.
          Diabetes Care 2006;29(1):44-50
          13) Kaufman FR, Gibson LC, Halvorson M, et al. A pilot study of the continuous
          glucose monitoring system: clinical decisions and glycemic control after its use in
          pediatric type 1 diabetic subjects. Diabetes Care 2001;24(12):2030-4
          14) Garg SK, Kelly WC, Voelmle MK, et al. Continuous home monitoring of glucose:
          improved glycemic control with real life use of continuous glucose sensors in adult
          subjects with type 1 diabetes. Diabetes Care 2007;30(12):3023-5
          15) Chase HP, Beck RW, Xing D, et al. Continuous glucose monitoring in youth
          with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation
          continuous glucose monitoring randomized trial. Diabetes Technol Ther 2010;12(7
          ):507-15
          16) Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved
          metabolic control in pediatric patients with type 1 diabetes: a controlled crossover
          study. Pediatrics 2003;111(5 Pt 1):933-8
          17) De Block C, Manuel-y-Keenoy B, Van Gaal L. A review of current evidence with
          continuous glucose monitoring in patients with diabetes. J Diabetes Sci Technol
          2008;2(4):718-27
          18) Vazeou A. Continuous blood glucose monitoring in diabetes treatment.
          Diabetes Res Clin Pract 2011;93 (Suppl.1):S125-30
          19) Harman-Boehm I. Continuous glucose monitoring in type 2 diabetes. Diabetes
          Res Clin Pract 2008;82 (Suppl.2):S118-21
          20) Vaddiraju et al. Technologies for Continuous Glucose Monitoring: Current
          Problems and Future Promises. J Diabetes Sci Technol 2010;4(6):1540-1562


    Photo:
    http://photos.prnewswire.com/prnh/20121024/567690

CONTACTO: Additional background information on 'Diabetes and continuousglucose monitoring' and 'C8 MediSensors and the Optical Glucose Monitor'are available from the European media contacts below.C8 MediSensors, Inc: Paul Zygielbaum, CEO, (+1) 408 622 2070; Fred Toney,CFO, (+1) 408 622 2050, Paul Connolly, VP Marketing & Sales, (+1) 408 7246453;European Media Contacts: UK: Aurora Healthcare Communications, Amy Noise /Rachel Terry, ((+44) 7720 592 689 / (+44) 7720 592 687, Germany: WaggenerEdstrom, Munich, Michaela Grandek, (+49) 89 628 1750, Spain: BerbesAssociados, Diana Zugasti / Sara Nieto,(+34) 91 563 23 00